Georgia Cannabis Operator Opens Facility Doors to Push Stalled Bills
A decade after Georgia legalized medical cannabis, the program remains narrow, and the legislature keeps stalling on bills meant to widen it. In Macon-Bibb, one of the state's three licensed medical
Cannabis Retailers Use Public Art to Fund LGBTQ+ Youth Services
A ribbon-cutting in downtown Ferndale this week marked the debut of "Polychromatic Super You," a 40-by-25-foot mural by Michigan artist Joey Salamon, installed in the alley at 258 W. Nine Mile Rd.
Nevada City Moves Toward Loosening Local Cannabis Code Restrictions
Nevada City is quietly positioning itself as an outlier among California municipalities still wary of retail cannabis, with the city council advancing a set of proposed amendments designed to ease
Online Slot Content Highlights Gaps in Cannabis Retail Compliance Standards
A recent roundup promoting real-money online slot machines for August 2026 landed in cannabis trade circles for an unusual reason: it has nothing to do with cannabis, yet its structure mirrors
Older Consumers Emerge as Untapped Growth Segment for Cannabis Retailers
Michigan's cannabis industry has spent the better part of three years chasing a demand problem that may not be a demand problem at all. Wholesale prices have collapsed, margins have thinned to almost
Oklahoma AG's Cannabis-Banking Ties Raise Conflict Questions Before Runoff
Gentner Drummond is asking Oklahoma Republicans for their votes Tuesday. He is also the chairman of Blue Sky Bank, an institution that has grown from roughly $200 million in assets in 2018 to more
Shared Bank Accounts Carry Hidden Stakes for Dispensary Households
Joint checking accounts solve a real problem: splitting rent, managing a parent's bills, teaching a teenager how money works. But the same account that simplifies household finances raises a separate
Cannabis Stocks Rally as Investors Bet on DEA Rescheduling Outcome
MSOS, the AdvisorShares Pure US Cannabis ETF, is trading at its highest levels of 2026, and the timing is not incidental. A DEA administrative hearing set for June 29 will examine whether marijuana
Analysts Split on Health In Tech as Insurance-Cannabis Bet Plays Out
Wall Street's read on Health In Tech, Inc. (NASDAQ: HIT) is anything but settled. Maxim Group's A. Klee reiterated a "Buy" rating and a $3.00 price target on Friday, August 14th, forecasting a loss